YD Bio Limited (YDES) Stock Statistics & Valuation Metrics

YD Bio Limited has a market cap or net worth of $153.70M. The enterprise value is $172.49M.

YD Bio Limited has 70,831,345 shares outstanding. The number of shares has decreased by -2.65% in one year.

YD Bio Limited’s return on equity (ROE) is 2.91 and return on invested capital (ROIC) is -43.41%.

The current PE Ratio of YD Bio Limited is ―. YD Bio Limited’s PEG ratio is 1.29.

In the last 12 months, YD Bio Limited had revenue of 596.82K and earned -8.31M in profits. Earnings per share was -0.12.

In the last 12 months, operating cash flow was -1.18M and capital expenditures -3.00, giving a free cash flow of -1.18M billion.

YD Bio Limited pays an annual dividend of ―, resulting in a dividend yield of ―

YD Bio Limited upcoming earnings date is Apr 30, 2026, After Close (Confirmed).

YD Bio Limited as a current ratio of 5.88, with Debt / Equity ratio of -0.24%

In the past 12 months, YD Bio Limited has paid -1.53K in taxes.

YD Bio Limited EV to EBITDA ratio is -99.63, with an EV/FCF ratio of -100.45.

YD Bio Limited has $6.31K in cash and marketable securities with $0.00 in debt, giving a net cash position of $6.31K billion.

Gross margin is 0.00%, with operating margin of -883.31%, and net profit margin of -1392.61%.

The average price target for YD Bio Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―